{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:56:50Z","timestamp":1779184610932,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016857","name":"CVPath Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.atherosclerosis.2017.10.014","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T20:05:21Z","timestamp":1508011521000},"page":"78-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A2 activity in atherosclerotic plaque"],"prefix":"10.1016","volume":"267","author":[{"given":"Fumiyuki","family":"Otsuka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoQing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh H.","family":"Trout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.","family":"Wasserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin H.","family":"Macphee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Krug-Gourley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena R.","family":"Ladich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloke V.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank D.","family":"Kolodgie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib1","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group","volume":"343","author":"Packard","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/01.CIR.0000156457.35971.C8","article-title":"Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study","volume":"111","author":"Winkler","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib3","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"Thompson","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejvs.2011.10.009","article-title":"Circulating lipoprotein-associated phospholipase A2 in high-grade carotid stenosis: a new biomarker for predicting unstable plaque","volume":"43","author":"Sarlon-Bartoli","year":"2012","journal-title":"Eur. J. Vasc. Endovascular Surg. Official J. Eur. Soc. Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib5","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/eurheartj\/ehs148","article-title":"Phospholipase A2 enzymes and the risk of atherosclerosis","volume":"33","author":"Rosenson","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib6","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/01.mol.0000174155.61307.5f","article-title":"Lipoprotein-associated phospholipase A2 as a target of therapy","volume":"16","author":"Macphee","year":"2005","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbrc.2008.03.087","article-title":"Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages","volume":"370","author":"Olofsson","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib8","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/01.ATV.19.12.2909","article-title":"Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions","volume":"19","author":"Hakkinen","year":"1999","journal-title":"Arteriosclerosis, Thrombosis, Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib9","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1161\/01.ATV.0000244681.72738.bc","article-title":"Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis","volume":"26","author":"Kolodgie","year":"2006","journal-title":"Arteriosclerosis, thrombosis, Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nm.1870","article-title":"Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development","volume":"14","author":"Wilensky","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib11","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/ATVBAHA.112.249854","article-title":"Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation","volume":"32","author":"Goncalves","year":"2012","journal-title":"Arteriosclerosis, Thrombosis, Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2796.2010.02258.x","article-title":"Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality","volume":"268","author":"Group, HPSC","year":"2010","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/hq0202.102918","article-title":"Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB","volume":"22","author":"Tsimihodimos","year":"2002","journal-title":"Arteriosclerosis, Thrombosis, Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib14","doi-asserted-by":"crossref","first-page":"34573","DOI":"10.1074\/jbc.M205059200","article-title":"Macrophage foam cell formation with native low density lipoprotein","volume":"277","author":"Kruth","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jacc.2011.10.852","article-title":"Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques","volume":"59","author":"Finn","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.1997.03550040069040","article-title":"Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials","volume":"278","author":"Hebert","year":"1997","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib17","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.10.013","article-title":"The pathology of atherosclerosis: plaque development and plaque responses to medical treatment","volume":"122","author":"Insull","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib18","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.0000144307.82502.32","article-title":"Histological correlates of carotid plaque surface morphology on lumen contrast imaging","volume":"110","author":"Lovett","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib19","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.105.589044","article-title":"Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study","volume":"113","author":"Redgrave","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jvs.2006.09.051","article-title":"Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy","volume":"45","author":"Hellings","year":"2007","journal-title":"J.\u00a0Vasc. Surg."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ab.2004.09.033","article-title":"Analysis of connective tissues by laser capture microdissection and reverse transcriptase-polymerase chain reaction","volume":"337","author":"Jacquet","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1369\/jhc.4A6401.2005","article-title":"Histological analysis of GFP expression in murine bone","volume":"53","author":"Jiang","year":"2005","journal-title":"J.\u00a0Histochem. Cytochem. Off. J. Histochem. Soc."},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2017.10.014_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00003495-199856001-00002","article-title":"New insights into plaque stabilisation by lipid lowering","volume":"56","author":"Libby","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0002-9149(90)90482-G","article-title":"Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest","volume":"66","author":"Kragel","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/ATVBAHA.108.173658","article-title":"Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization","volume":"29","author":"Peeters","year":"2009","journal-title":"Arteriosclerosis, Thrombosis, Vasc. Biol."},{"issue":"584","key":"10.1016\/j.atherosclerosis.2017.10.014_bib26","first-page":"e581","article-title":"Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial","volume":"155","author":"Underhill","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib27","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.108.771899","article-title":"Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque","volume":"118","author":"Serruys","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib28","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1161\/CIRCULATIONAHA.105.612630","volume":"113","author":"O'Donoghue","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2005.05.006","article-title":"The effect of statin therapy on lipoprotein associated phospholipase A2 levels","volume":"182","author":"Albert","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1373\/clinchem.2011.180281","article-title":"Relationship of lipoprotein-associated phospholipase A(2) mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial","volume":"58","author":"Ridker","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib31","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1185\/03007995.2010.509264","article-title":"Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters","volume":"26","author":"Karalis","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2013.08.013","article-title":"Comparison of the effect of simvastatin versus simvastatin\/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia","volume":"231","author":"Moutzouri","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib33","doi-asserted-by":"crossref","first-page":"e000360","DOI":"10.1161\/JAHA.113.000360","article-title":"Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study","volume":"2","author":"White","year":"2013","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/FJC.0b013e31820376ac","article-title":"Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway","volume":"57","author":"Song","year":"2011","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib35","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/STROKEAHA.107.503193","article-title":"Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques","volume":"39","author":"Mannheim","year":"2008","journal-title":"Stroke; J. Cereb. Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib36","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1056\/NEJMoa1315878","article-title":"Darapladib for preventing ischemic events in stable coronary heart disease","volume":"370","author":"White","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib37","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.2014.11061","article-title":"Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial","volume":"312","author":"O'Donoghue","year":"2014","journal-title":"Jama"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib38","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib39","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1161\/STROKEAHA.113.002551","article-title":"Carotid plaque MRI and stroke risk: a systematic review and meta-analysis","volume":"44","author":"Gupta","year":"2013","journal-title":"Stroke; J. Cereb. Circulation"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib40","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacc.2013.06.015","article-title":"Meta-analysis and systematic review of the predictive value of carotid plaque hemorrhage on cerebrovascular events by magnetic resonance imaging","volume":"62","author":"Saam","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.atherosclerosis.2013.07.008","article-title":"Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events","volume":"230","author":"Ijas","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib42","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/ATVBAHA.112.252122","article-title":"Genotype-dependent impairment of hemoglobin clearance increases oxidative and inflammatory response in human diabetic atherosclerosis","volume":"32","author":"Purushothaman","year":"2012","journal-title":"Arteriosclerosis, Thrombosis, Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib43","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1161\/ATVBAHA.112.300173","article-title":"Phenotypic polarization of macrophages in atherosclerosis","volume":"33","author":"Leitinger","year":"2013","journal-title":"Arteriosclerosis, Thrombosis, Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib44","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2353\/ajpath.2009.080431","article-title":"Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype","volume":"174","author":"Boyle","year":"2009","journal-title":"Am. J. Pathology"},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib45","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/bj20030636","article-title":"Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages","volume":"375","author":"Wu","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib46","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jacc.2011.11.019","article-title":"Translational studies of lipoprotein-associated phospholipase A(2) in inflammation and atherosclerosis","volume":"59","author":"Ferguson","year":"2012","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.014_bib47","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1194\/jlr.R045492","article-title":"To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase","volume":"55","author":"Marathe","year":"2014","journal-title":"J.\u00a0Lipid Res."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T17:04:02Z","timestamp":1659632642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017313345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":47,"alternative-id":["S0021915017313345"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.014","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A2 activity in atherosclerotic plaque","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}